NTN BUZZTIME INC. overview

Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today announced the completion of the reverse merger with NTN Buzztime, Inc. Brooklyn will focus on the advancement of IRX-2, its cytokine-based compound for the treatment of various cancers, as well as opportunities in the area of gene editing/cell therapy through its option agreement with...

NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger PR Newswire CARLSBAD, Calif., March 23, 2021 CARLSBAD, Calif. , March 23, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021 . The shares of common...

NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting PR Newswire CARLSBAD, Calif., March 15, 2021 CARLSBAD, Calif. , March 15, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that its stockholders have approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics LLC. The proposed merger remains subject to further customary closing conditions and regulatory approvals. NTN expects that the merger will...

Independent Advisory Firm ISS Recommends NTN Stockholders Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals PR Newswire CARLSBAD, Calif., March 8, 2021 CARLSBAD, Calif. , March 8, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") recommends that NTN stockholders vote "FOR" ALL PROPOSALS to be considered and voted on at the March 15, 2021 special meeting of...

NTN Buzztime Board of Directors Urges Stockholders to Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals PR Newswire CARLSBAD, Calif., March 1, 2021 CARLSBAD, Calif. , March 1, 2021 /PRNewswire/ -- The board of directors of NTN Buzztime, Inc. (NYSE American: NTN) unanimously urges NTN's stockholders to vote FOR ALL the proposals to be voted on at the March 15, 2021 special meeting of stockholders, all of which relate to the proposed merger involving NTN and Brooklyn...

Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “ Company ”), announced that as of January 29, 2021, the Company had purchased an aggregate of 295,000 shares of common stock or 9.96% equity interest in NTN Buzztime, Inc. (NYSE American: NTN) (“ NTN ”). The Company purchased the shares of common stock at a weighted average price of $3.42 per share in the open market, for total gross proceeds of $1,010,095. For further information, see the Schedule 13D...

NTN Buzztime Announces Date of Special Meeting of Stockholders to Vote on Proposed Merger and Asset Sale PR Newswire CARLSBAD, Calif., Feb. 3, 2021 CARLSBAD, Calif. , Feb. 3, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN), today announced that its registration statement on Form S-4 relating to the proposed merger involving NTN and Brooklyn ImmunoTherapeutics LLC (" Brooklyn ") and the proposed sale of NTN's assets to eGames.com Holdings LLC ("eGames.com") has been declared...

...